HomeHealthcare & Life SciencesPharmaceuticals Muscle Wasting Disorders Market

United Arab Emirates Muscle Wasting Disorders Market Size & Outlook, 2025-2033


United Arab Emirates Muscle Wasting Disorders Market Insights

  • Based on Reed Intelligence findings, the United Arab Emirates Muscle Wasting Disorders Market reached USD 307.82 Million in 2024 and is estimated to attain USD 581.02 Million by 2033.
  • From 2026 to 2033, the United Arab Emirates market is expected to grow at a steady CAGR of 7.2%.
  • Within the Disease Type category, Muscular Dystrophy dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Spinal Muscular Atrophy is forecasted to deliver the fastest growth, positioning it as the most lucrative Disease Type segment.

Other Key Findings


  • As of 2024, United Arab Emirates held 3.38% of the global Muscle Wasting Disorders Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Muscle Wasting Disorders Market.
  • In Middle East and Africa, United Arab Emirates is expected to lead the regional Muscle Wasting Disorders Market size by 2033.
  • United Arab Emirates will remain the fastest-growing market in Middle East and Africa, reaching USD 575.49 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 307.82 Million
Market Size In 2033 USD 581.02 Million
Largest segment Muscular Dystrophy
Units Revenue in USD Million
CAGR 7.2% (2025-2033)
Segmnetation Covered
Disease Type
  1. Muscular Dystrophy
  2. Spinal Muscular Atrophy
  3. Amyotrophic Lateral Sclerosis (ALS)
  4. Myasthenia Gravis
  5. Other Muscle Wasting Disorders
Treatment Modality
  1. Drug Therapies
  2. Gene Therapy
  3. Physical Therapy and Rehabilitation
  4. Supplements and Nutrition
  5. Other Treatment Modalities
Mechanism of Action
  1. Anti-inflammatory Agents
  2. Muscle Growth Stimulators
  3. Gene Editing Therapies
  4. Immunomodulators
  5. Other Mechanisms of Action
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports